Laddar...
SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
INTRODUCTION Teriparatide is a recombinant endogenous parathyroid hormone. It is an anabolic medication which is FDA approved for treating Osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis and Glucocorticoid-induced osteoporosis. Transient hypercalcemia with Teripara...
Sparad:
| I publikationen: | J Endocr Soc |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Endocrine Society
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552103/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-505 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|